Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab

BACKGROUND: Tumor necrosis factor inhibitor therapy for rheumatoid arthritis (RA) patients reduces disease activity, but little is known about the factors that correlate with continuation of remission. To identify demographics and clinical characteristics associated with achievement and continuation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Noriko, Suzuki, Katsuya, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432758/
https://www.ncbi.nlm.nih.gov/pubmed/30956738
http://dx.doi.org/10.1186/s41232-019-0094-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432758/
https://www.ncbi.nlm.nih.gov/pubmed/30956738
http://dx.doi.org/10.1186/s41232-019-0094-0

Ejemplares similares